)
Edge12 Jun 2026
Set in Stone: The Story of Richemont
From a South African tobacco company to Cartier, a deep dive into how Richemont built one of the world's leading hard luxury empires.
Taysha Gene Therapies
Taysha Gene Therapies (TSHA) investor relations material
Taysha Gene Therapies AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.AGM 2026 summary1 Jun, 2026
Opening remarks and agenda
Meeting commenced virtually with introductions of board members, management, independent auditor, and legal counsel.
Formal business followed the agenda outlined in the notice and proxy statement.
Board and executive committee updates
Two Class III directors, Sean P. Nolan and Laura Sepp-Lorenzino, were nominated for election to serve until the 2029 annual meeting.
Shareholder proposals
Four proposals were presented: election of directors, ratification of the independent auditor, advisory vote on executive compensation, and advisory vote on the frequency of future compensation votes.
Analyze the 84.86% stockholder quorum
Assess governance via director terms ending 2029
Evaluate impact of annual executive pay votes
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Taysha Gene Therapies
- TSHA-102 pivotal trials advance with strong safety, FDA alignment, and widened Q1 2026 net loss.TSHA
Q1 20266 May 2026 - TSHA-102 trials progressed with strong safety, regulatory alignment, and robust cash position.TSHAQ4 20256 May 2026
- Annual meeting covers director elections, auditor ratification, and executive pay votes.TSHAProxy filing22 Apr 2026
- Proxy covers director elections, auditor ratification, executive pay, and governance matters.TSHAProxy filing22 Apr 2026
- TSHA-102 delivers sustained, multi-domain benefits and safety in Rett syndrome, advancing to high-dose trials.TSHAStatus Update3 Feb 2026
- TSHA-102 trials showed strong safety, efficacy, and cash runway into Q4 2026 after $76.8M raise.TSHAQ2 20241 Feb 2026
- TSHA-102 shows clinical progress, regulatory momentum, and strong cash runway into Q4 2026.TSHAQ3 202414 Jan 2026
- TSHA-102 Phase II trials completed dosing with strong safety, efficacy, and cash runway into 2026.TSHAQ4 202423 Dec 2025
- Up to $300M in securities registered to fund gene therapy pipeline, led by Rett syndrome program.TSHARegistration Filing16 Dec 2025
Next Taysha Gene Therapies earnings date
Q2 202611 Aug, 2026
Taysha Gene Therapies
Next Taysha Gene Therapies earnings date
Q2 202611 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage